1 / 1

Industry Adverse Event Subcommittee (*= SC member)

Industry Adverse Event Subcommittee (*= SC member). Jackie Gough, ImClone Paul Mulhern, CBIIT, NCI Liviu Niculescu , M.D., Pfizer *Dianne Reeves, R.N., CBIIT, NCI Stephen Rubin, M.D., GlaxoSmithKline Mark Russo, M.D., GlaxoSmithKline Gwen Samuel, Bristol-Myers Squibb

belle
Download Presentation

Industry Adverse Event Subcommittee (*= SC member)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Industry Adverse EventSubcommittee(*= SC member) • Jackie Gough, ImClone • Paul Mulhern, CBIIT, NCI • LiviuNiculescu, M.D., Pfizer • *Dianne Reeves, R.N., CBIIT, NCI • Stephen Rubin, M.D., GlaxoSmithKline • Mark Russo, M.D., GlaxoSmithKline • Gwen Samuel, Bristol-Myers Squibb • AlissaScalera, Ph.D.m,Pfizer • John Speakman, CBIIT, NCI • Ann Setser, R.N., CBIIT, NCI • Joyce Steinberg, MD, AstellasPharma • Simon Voss, ImClone • James A. Zwiebel, M.D., CTEP, NCI • Helen Chen, M.D, CTEP, NCI • Nathan Enas, MS Lilly • Diane Paul, Patient Advocate • Eileen Monge, BSN, RN Genentech • Anne Tompkins, RN, DCP, NCI • *Jeff Abrams, M.D., Cancer Therapy Evaluation Program (CTEP), NCI • Isaac Adegbile, ImClone • Deyaa Adib, Astellas Pharma • Cheryl Anderson, ImClone • *Rebecca Benner,Ph.D., Pfizer • Mark Benyunes, M.D., Genentech • Maria Bonura, Pfizer • Sophia Calmels, Ph.D., Pfizer • Jan Casadei, M.D., CTEP, NCI • Lorna Charles, M.D., Pfizer • Neesha Desai (Facilitator), Center for Biomedical Informatics and Information Technology (CBIIT), NCI • Robert Friedman, GlaxoSmithKline • Sherry Ansher, Ph.D, CTEP, NCI • John Freymann, CBIIT, NCI • Mark Steinberg, M.D., GlaxoSmithKline

More Related